Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity
Yuan Cao1, Clare Y Slaney1, Bradley N Bidwell1
1Research Division, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
Abstract:
The TGFβ growth factor family member BMP4 is a potent suppressor of breast cancer metastasis. In the mouse, the development of highly metastatic mammary tumors is associated with an accumulation of myeloid-derived suppressor cells (MDSC), the numbers of which are reduced by exogenous BMP4 expression. MDSCs are undetectable in naïve mice but can be induced by treatment with granulocyte colony-stimulating factor (G-CSF/Csf3) or by secretion of G-CSF from the tumor. Both tumor-induced and G-CSF-induced MDSCs effectively suppress T-cell activation and proliferation, leading to metastatic enhancement. BMP4 reduces the expression and secretion of G-CSF by inhibiting NF-κB (Nfkb1) activity in human and mouse tumor lines. Because MDSCs correlate with poor prognosis in patients with breast cancer, therapies based on activation of BMP4 signaling may offer a novel treatment strategy for breast cancer. Cancer Res; 74(18); 5091-102. ©2014 AACR.
Insights
Bone morphogenetic protein 4 (BMP4) suppresses breast cancer metastasis by reducing myeloid-derived suppressor cells (MDSCs). BMP4 inhibits granulocyte colony-stimulating factor (G-CSF) secretion, offering a potential new therapy for breast cancer patients.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Breast cancer metastasis is a major cause of mortality.
- Myeloid-derived suppressor cells (MDSCs) promote tumor metastasis.
- Granulocyte colony-stimulating factor (G-CSF) induces MDSCs, enhancing metastasis.
Purpose of the Study:
- To investigate the role of BMP4 in suppressing breast cancer metastasis.
- To elucidate the mechanism by which BMP4 affects MDSCs and G-CSF.
Main Methods:
- Utilized mouse models of mammary tumors.
- Administered exogenous BMP4 to tumor-bearing mice.
- Assessed MDSC accumulation and T-cell suppression.
- Analyzed G-CSF expression and NF-κB activity in tumor cells.
Main Results:
- Exogenous BMP4 expression reduced MDSC accumulation in metastatic mammary tumors.
- BMP4 inhibited both tumor-induced and G-CSF-induced MDSCs.
- BMP4 decreased G-CSF expression and secretion by inhibiting NF-κB activity.
- MDSCs were found to suppress T-cell activation and proliferation.
Conclusions:
- BMP4 is a potent suppressor of breast cancer metastasis.
- BMP4 functions by reducing MDSCs, partly through inhibiting G-CSF secretion via NF-κB.
- Targeting BMP4 signaling represents a promising therapeutic strategy for breast cancer.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules

